Voltage regulator producer Empower closed a $45m round featuring Samsung Catalyst Fund while Swisscom and Six-backed spend management software provider Yokoy raised $26m.

The gastrointestinal disorder drug developer was co-founded by researchers from Stanford University.

Eli Lilly, MRL Ventures Fund and Leaps by Bayer were among the participants in a round disclosed as the gastrointestinal disorder drug developer launched.

The SoftBank and Hearst-backed creative marketing provider has secured the first tranche of its series D round at a $1bn valuation.

The TigerMed-backed clinical research provider reportedly secured near to $100m in a round co-led by Sequoia Capital China and GL Ventures.

The cancer therapeutics developer has followed up an Eli Lilly-backed first close with an extra $25m, taking the round to $82.6m.

Stripe invested in the tax management software developer through a series C round which reportedly almost tripled its valuation to $700m.

Susquehanna International Group and Globe Telecom returned to reinvest in the livestream platform developer through a $73.6m round.

The digital therapeutics developer closed a series B round that included corporate venturing units and existing investors Hikma Ventures and Sanofi Ventures.

Takeda Ventures was among the participants in a $46.5m round closed nearly a year after its parent company launched a partnership with the immunotherapy developer.